![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, January 18, 2021 2:13:35 PM
https://investorshub.advfn.com/Response-Genetics-Inc-RGDXQ-9727/
https://www.cancergenetics.com/ [CANCER STUFF]
Cancer Genetics to Present at the 2021 BioConnect Virtual Conference Hosted by H.C. Wainwright
https://www.cancergenetics.com/news-media/press-releases/detail/1264/cancer-genetics-to-present-at-the-2021-bioconnect-virtual
Super Tiny float: 27M shares in which only a few millions shares available for trading!
Super Tiny OS: 38M shares.
Restricted: 11,453,751 shares.
Tiny AS: 70M shares.
Asset Value: $0.361 per share.
Cash Value: $0.1805 per share.
Enterprise Value: $0.24 per share.
Analyst's Target: $0.4686 per share.
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM